Abstract
As was demonstrated in many of the chapters in this volume, the compartmentation of amino acid metabolism in brain is directly correlated with the fact that amino acids such as glutamate must function at several levels, e.g., in protein metabolism, in maintaining energy requirements, as well as perhaps having a direct role in nerve transmission as neurotransmitters or neuromodulator substances. Indeed, evidence continues to accumulate concerning the role of amino acids as putative transmitters in the CNS (see other chapters in this volume). Roberts and Matthysse (1970), among others, have postulated that the physiological interplay of the excitatory and inhibitory systems that interact to maintain homeostasis raises the possibility that biochemical cross-regulation may exist between synapses with different neurotransmitter systems. Watkins (1973) has also reviewed the possibility of metabolic regulation in transmitter processes. In addition, transmitter release, uptake, and metabolism require energy. Since glutamate and its related metabolites are directly associated with the tricarboxylic acid cycle, it might be expected that the metabolic turnover of these amino acids would also reflect the energy needs of the brain.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Amano, T., Richelson, E., and Nirenberg, M., 1972, Neurotransmitter synthesis by Neuroblastoma clones, Proc. Natl Acad. Sci U.S.A. 69: 258–63.
Axelrod, J., 1972, Dopamines-β-hydroxylase: Regulation of its synthesis and release from nerve terminals, Pharmacol Rev. 24: 233–43.
Baldás, R., Machiyama, Y., Hammond, B. J., Julian, T., and Richter, D., 1970, The operation of the GAB A bypath of the tricarboxylic acid cycle in brain tissue in vitro, Biochem J. 116: 445–61.
Baldás, R., Patel, A. J., and Richter, D., 1973, Compartmentation and the metabolism of γ-amino-butyrate, “Metabolic Compartmentation in the Brain” (R. Baldás and J. Cremer, eds.), p. 167, Macmillan, London.
Berl, S., 1971, Cerebral amino acid metabolism in hepatic coma, Exp. Biol. Med. 4: 71–84.
Berl, S., and Clarke, D. D., 1972, Effects of Li+ on the metabolism in brain of glutamate, glutamine, aspartate and GAB A from [1-14 C] acetate in vitro, Brain Res. 36: 203–13.
Berl, S., and Frigyesi, T., 1969, Effect of reserpine on turnover of glutamate, glutamine, aspartate and GABA labeled with [1-14 C] acetate in caudate nucleus, thalamus and sensorimotor cortex (cat), Brain Res. 14: 683–95.
Berl, S., Takagaki, G., Clarke, D. D., and Waelsch, H., 1962, Metabolic compartments in vivo: Ammonia and glutamic acid metabolism in brain and liver, Biol. Chem. 237: 2562–2568.
Berl, S., Nicklas, W. J., and Clarke, D. D., 1968, Compartmentation of glutamic acid metabolism in brain slices, J. Neurochem. 15: 131–40.
Black, I. B., and Axelrod, J., 1969, Inhibition of tyrosine transaminase activity by norepinephrine, J. Biol. Chem. 244: 6124–6129.
Bloom, F. E., Algeri, S., Groppetti, A., Revuelta, A., and Costa, E., 1969, Lesions of central norepinephrine terminals with 6-hydroxydopamine: Biochemistry and fine structure, Science 166: 1284–86.
Breese, G. R., and Traylor, T. D., 1970, Effect of 6-hydroxydopamine on brain norepinephrine and dopamine: Evidence for selective degeneration of catecholamine neurons, J. Pharmacol. Exp. Ther. 174: 413–20.
Cavanagh, J. B., and Kyu, M. H., 1971, On the mechanism of type I Alzheimer abnormality in the nuclei of astrocytes, J. Neurol Sci. 12: 241–261.
Collins, G. G. S., 1973, Effect of aminoxyacetic acid, thiosemicarbizide and haloperidol on the metabolism and half-lives of glutamate and GABA in rat brain, Biochem. Pharmacol. 22: 101–111.
De Feudis, F. V., and Delgado, J. M. R., 1970, Effects of lithium on amino acids in mouse brain in vivo, Nature (London) 225: 749–50.
Goldstein, M., Joh, T. H., and Garvey, T. Q., 1968, Kinetic studies of the enzymatic dopamines-β-hydroxylase reaction, Biochemistry 7: 2724–30.
Kremzner, L. T., Berl, S., Mendoza, M., and Yahr, M. D., 1973, Cerebrospinal fluid levels of dopa and 3-0-methyldopa in Parkinsonism during treatment with L-dopa and MK-486, in “Advances in Neurology,” Vol. 2, pp. 79–89, Raven Press, New York.
Lahiri, S., and Quastel, J. H., 1963, Fluoroacetate and the metabolism of ammonia in brain, Biochem. J. 89: 157–163.
Levin, E. Y., Levenberg, B., and Kaufman, S., 1960, The enzymatic conversion of 3,4-dihydroxy- phenylethylamine to norepinephrine, J. Biol Chem. 235: 2080–2086.
Liu, Y. P., Ambani, L. M., and Van Woert, M. H., 1972, L-Dihydroxyphenylalanine: Effect on levels of amino acids in rat brain, J. Neurochem. 19: 2237–2239.
Malmfors, T., and Thoenen, H., eds., 1971, “6-Hydroxydopamine and Catecholamine Neurons,” North Holland, Amsterdam.
Neff, N. H., and Costa, E., 1968, Application of steady state kinetics to study of catecholamine turnover after MAO inhibition or reserpine administration, J. Pharmacol Exp. Ther. 160: 40–47.
Ng, K. Y., Colburn, R. W., and Kopin, I. J., 1971, Effects of L-DOPA on efflux of cerebral monoamines from synaptosomes, Nature (London) 230: 331–332.
Nicklas, W. J., and Berl, S., 1973, In vivo studies on the effect of 6-hydroxydopamine on amino acid metabolism in brain, Brain Res. 61: 343–56.
Nicklas, W. J., Berl, S., and Clarke, D. D., 1974, Interaction of catecholamine and amino acid metabolism in brain: Effect of pargyline and L-DOPA, J. Neurochem. 23: 149–157.
Parkes, J. D., Shaipstone, P., and Williams, R., 1970, Levodopa in hepatic coma, Lancet 11: 1341–43.
Pletscher, A., 1972, Regulation of catecholamine turnover by variations of enzyme levels, Pharmacol Rev. 24: 225–32.
Popov, N., and Matthies, H., 1969, Some effects of MAO inhibitors on the metabolism of GAB A in brain, J. Neurochem. 16: 899–907.
Reis, D. J., and Molinoff, P. B., 1972, Brain dopamines-β-hydroxylase: Regional distribution and effects of lesions and 6-hydroxydopamine on activity, J. Neurochem. 19: 195–204.
Roberts, E., and Matthysse, S., 1970, Neurochemistry: At the crossroads of neurobiology, Annu. Rev. Biochem. 39: 777–820.
Santini, M., and Berl, S., 1972, Effects of reserpine and MAO inhibition on the levels of amino acids in sensory ganglia, sympathetic ganglia and spinal cord, Brain Res. 47: 167–76.
Schildkraut, J. J., Schanberg, S. M., and Kopin, I. J., 1966, The effect of lithium on [3H] norepinephrine metabolism in brain, Life Sci. 5: 1479–83.
Sethy, V. H., and Van Woert, M. H., 1973, Effect of L-DOPA on brain acetylcholine in rats, Neuropharmacology 12: 27–31.
Tyce, G. M., 1971, Effect of dihydroxyphenylalanine administered with a monoamine oxidase inhibitor on glucose metabolism in rat brain, Biochem. Pharmacol 20: 2371–84.
Valzelli, L., and Garattini, S., 1968, Biogenic amines in discrete brain areas after treatment with monoamine oxidase inhibitors, J. Neurochem. 15: 259–61.
Van den Berg, C. J., 1970, Glutamate and glutamine, in “Handbook of Neurochemistry,” Vol. 3, p. 355, Plenum Press, New York.
Van den Berg, C. J., and Garfinkel, D., 1971, A simulation study of brain compartments, Biochem. J. 123: 211–218.
Van Hosslin, C., and Alzheimer, A., 1912, Ein Beitrag zur Klinik und pathologischen Anatomie der Westphal-Strumpellschen Pseudo-Sklerose, Z. Ges. Neurol Psychiatr. 8: 183–209.
Waggoner, R. W., and Malamud, N., 1942, Wilson’s disease in the light of cerebral changes following acquired liver disorders, J. Nerv. Ment. Dis. 96: 410–23.
Watkins, J. C., 1973, Metabolic regulation in the release and action of excitatory and inhibitory amino acids in the central nervous system, Biochem. Soc. Symp. 36: 33–47.
Watson, W. E., 1972, Some quantitative observations upon the responses of neuroglial cells which follow axotomy of adjacent neurones. J. Physiol (London) 225: 415–35.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1975 Plenum Press, New York
About this chapter
Cite this chapter
Nicklas, W.J., Berl, S., Clarke, D.D. (1975). Relationship between Amino Acid and Catecholamine Metabolism in Brain. In: Berl, S., Clarke, D.D., Schneider, D. (eds) Metabolic Compartmentation and Neurotransmission. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-4319-6_30
Download citation
DOI: https://doi.org/10.1007/978-1-4613-4319-6_30
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4321-9
Online ISBN: 978-1-4613-4319-6
eBook Packages: Springer Book Archive